Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Change in Taxes (2024 - 2025)

OptimizeRx (OPRX) has disclosed Change in Taxes for 2 consecutive years, with $995000.0 as the latest value for Q4 2025.

  • Quarterly Change in Taxes rose 202.37% to $995000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.1 million through Dec 2025, changed N/A year-over-year, with the annual reading at -$1.1 million for FY2025, N/A changed from the prior year.
  • Change in Taxes hit $995000.0 in Q4 2025 for OptimizeRx, up from -$1.1 million in the prior quarter.
  • In the past five years, Change in Taxes ranged from a high of $1.8 million in Q3 2024 to a low of -$1.2 million in Q2 2024.